- Home
- KRMD vs MYPS Comparison
KRMD vs MYPS Comparison
Compare KRMD & MYPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- MYPS
- Stock Information
- Founded
- KRMD 1980
- MYPS 2011
- Country
- KRMD United States
- MYPS United States
- Employees
- KRMD N/A
- MYPS N/A
- Industry
- KRMD Medical/Dental Instruments
- MYPS EDP Services
- Sector
- KRMD Health Care
- MYPS Technology
- Exchange
- KRMD Nasdaq
- MYPS Nasdaq
- Market Cap
- KRMD 134.3M
- MYPS 131.5M
- IPO Year
- KRMD N/A
- MYPS N/A
- Fundamental
- Price
- KRMD $4.17
- MYPS $1.02
- Analyst Decision
- KRMD Strong Buy
- MYPS Buy
- Analyst Count
- KRMD 4
- MYPS 6
- Target Price
- KRMD $4.63
- MYPS $2.80
- AVG Volume (30 Days)
- KRMD 131.8K
- MYPS 253.3K
- Earning Date
- KRMD 08-06-2025
- MYPS 08-04-2025
- Dividend Yield
- KRMD N/A
- MYPS N/A
- EPS Growth
- KRMD N/A
- MYPS N/A
- EPS
- KRMD N/A
- MYPS N/A
- Revenue
- KRMD $36,848,451.00
- MYPS $261,058,000.00
- Revenue This Year
- KRMD $18.16
- MYPS N/A
- Revenue Next Year
- KRMD $14.60
- MYPS $0.89
- P/E Ratio
- KRMD N/A
- MYPS N/A
- Revenue Growth
- KRMD 19.57
- MYPS N/A
- 52 Week Low
- KRMD $1.86
- MYPS $1.00
- 52 Week High
- KRMD $5.05
- MYPS $2.29
- Technical
- Relative Strength Index (RSI)
- KRMD 66.43
- MYPS 28.78
- Support Level
- KRMD $4.08
- MYPS $1.00
- Resistance Level
- KRMD $4.34
- MYPS $1.07
- Average True Range (ATR)
- KRMD 0.22
- MYPS 0.06
- MACD
- KRMD 0.07
- MYPS -0.00
- Stochastic Oscillator
- KRMD 85.09
- MYPS 8.00
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About MYPS PLAYSTUDIOS Inc.
PLAYSTUDIOS Inc is engaged in gaming and related business. The Company develops and operates online and mobile social gaming applications (games or game), many of which incorporate a loyalty program offering real world rewards provided by a collection of awards partners. The Company's games are free-to-play and available via the Apple App Store, Google Play Store, Amazon Appstore and Facebook (collectively, platforms or platform operators). The Company creates games based on its own original content as well as third-party licensed brands. The Company generates revenue through the in-game sales of virtual currency and through advertising. The company has one operating segment with one business activity, developing and monetizing social games.